Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Synairgen (SYNG)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
6.24 +0.04    +0.65%
16:35:59 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 365,977
  • Bid/Ask: 5.50 / 6.50
  • Day's Range: 5.52 - 6.45
Type:  Equity
Market:  United Kingdom
ISIN:  GB00B0381Z20 
SEDOL:  B0381Z2
Synairgen 6.24 +0.04 +0.65%

Synairgen Latest Cash Flow Statement

 
Use the Synairgen cash flow statement to assess the changes in SYNG's cash and cash equivalents.

The SYNG cash flow chart shows Net Income, Cash from Operating, Financing and Investing Activities, as well as Synairgen free cash flow, yield and ending cash balance.
AnnualQuarterly
InvestingPro Advanced Cash Flow Statement
Period Ending: 2023
30/06
2023
31/03
2022
31/12
2022
30/09
Period Length: 0 Months 0 Months 0 Months 0 Months
Net Income/Starting Line - - -2.62 -2.62
Cash From Operating Activities - - 0.768 0.768
Depreciation/Depletion - - 0.023 0.023
Amortization - - 0.002 0.002
Deferred Taxes - - 4.54 4.54
Non-Cash Items - - 4.32 4.32
Cash Receipts - - - -
Cash Payments - - - -
Cash Taxes Paid - - -4.54 -4.54
Cash Interest Paid - - - -
Changes in Working Capital - - -0.954 -0.954
Cash From Investing Activities - - -1.82 -1.82
Capital Expenditures - - -0.001 -0.001
Other Investing Cash Flow Items, Total - - -1.81 -1.81
Cash From Financing Activities - - - -
Financing Cash Flow Items - - - -
Total Cash Dividends Paid - - - -
Issuance (Retirement) of Stock, Net - - - -
Issuance (Retirement) of Debt, Net - - - -
Foreign Exchange Effects - - - -
Net Change in Cash - - -1.05 -1.05
Beginning Cash Balance - - 16.97 16.97
Ending Cash Balance - - 15.93 15.93
Free Cash Flow - - -1.64 4.61
Free Cash Flow Growth - - -135.7 209.85
Free Cash Flow Yield - - 2.82 2.3
* In Millions of GBP (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

SYNG Price Commentary

Write your thoughts about Synairgen
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Nicholas Aldam
Nicholas Aldam May 17, 2022 8:15
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.marketwatch.com/story/synairgen-shares-rise-on-positive-analysis-of-phase-3-covid-19-treatment-trial-271652687610
Sarah Froggatt
Sarah Froggatt May 16, 2022 10:12
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.synairgen.com/media/synairgen-presents-at-ats-2022
Nicholas Aldam
Nicholas Aldam May 16, 2022 8:38
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Presenting to the ATS today, also rumours for a takeover…
Nicholas Aldam
Nicholas Aldam Apr 26, 2022 8:59
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Though brief, interesting read and move in the right direction: https://www.synairgen.com/media/presentation-at-eccmid
Elliot dd
Elliot dd Apr 14, 2022 9:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
New promosing drug on the market in the name of VERU. Short Synairgen under 10
Nicholas Aldam
Nicholas Aldam Mar 22, 2022 7:56
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Polygon position, Polygon Global Partners LLP 50,927,428 Ordinary shares (25.3%). Major shareholder, in at different levels, will they sell out, NOPE
Nicholas Aldam
Nicholas Aldam Mar 18, 2022 14:43
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why shouldnt there be a recovery? Polygon still have a major position and speaks volumes, IMO. On unpteen occasions i have said the company are not just covid related researches but also many lung related conditions are u der the microscope. Defo HOLD
Harry Carson
Harry Carson Mar 18, 2022 10:31
Saved. See Saved Items.
This comment has already been saved in your Saved Items
recovery?
Nicholas Aldam
Nicholas Aldam Mar 17, 2022 9:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Indeed, oops
Harry Carson
Harry Carson Mar 17, 2022 9:29
Saved. See Saved Items.
This comment has already been saved in your Saved Items
oops
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email